257 related articles for article (PubMed ID: 26436463)
1. The role of cardiorespiratory fitness on plasma lipid levels.
Parto P; Lavie CJ; Swift D; Sui X
Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1177-83. PubMed ID: 26436463
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia therapy update: the importance of full lipid profile assessment.
Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G
Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582
[TBL] [Abstract][Full Text] [Related]
3. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Cardiorespiratory Fitness Levels on the Risk of Developing Atherogenic Dyslipidemia.
Breneman CB; Polinski K; Sarzynski MA; Lavie CJ; Kokkinos PF; Ahmed A; Sui X
Am J Med; 2016 Oct; 129(10):1060-6. PubMed ID: 27288861
[TBL] [Abstract][Full Text] [Related]
5. Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects.
Hernández-Mijares A; Ascaso JF; Blasco M; Brea Á; Díaz Á; Mantilla T; Pedro-Botet J; Pintó X; Millán J;
Clin Investig Arterioscler; 2019; 31(2):75-88. PubMed ID: 30262442
[TBL] [Abstract][Full Text] [Related]
6. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
7. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
8. Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
Quispe R; Al-Hijji M; Swiger KJ; Martin SS; Elshazly MB; Blaha MJ; Joshi PH; Blumenthal RS; Sniderman AD; Toth PP; Jones SR
J Clin Lipidol; 2015; 9(4):511-8.e1-5. PubMed ID: 26228668
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
Raal FJ
Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742
[TBL] [Abstract][Full Text] [Related]
10. Both poor cardiorespiratory and weak muscle fitness are related to a high concentration of oxidized low-density lipoprotein lipids.
Kosola J; Ahotupa M; Kyröläinen H; Santtila M; Vasankari T
Scand J Med Sci Sports; 2012 Dec; 22(6):746-55. PubMed ID: 21545538
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
[TBL] [Abstract][Full Text] [Related]
12. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
13. Water-Based Aerobic Training Successfully Improves Lipid Profile of Dyslipidemic Women: A Randomized Controlled Trial.
Costa RR; Pilla C; Buttelli ACK; Barreto MF; Vieiro PA; Alberton CL; Bracht CG; Kruel LFM
Res Q Exerc Sport; 2018 Jun; 89(2):173-182. PubMed ID: 29578858
[TBL] [Abstract][Full Text] [Related]
14. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
15. Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study.
Wang Q; Ding H; Xu J; Geng W; Liu J; Guo X; Kang J; Li X; Jiang Y; Shang H
Lipids Health Dis; 2016 Sep; 15(1):149. PubMed ID: 27600391
[TBL] [Abstract][Full Text] [Related]
16. Lipids for psychiatrists - an overview.
Young IS
J Psychopharmacol; 2005 Nov; 19(6 Suppl):66-75. PubMed ID: 16280339
[TBL] [Abstract][Full Text] [Related]
17. Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
Guardiola M; Plana N; Ibarretxe D; Cabré A; González M; Ribalta J; Masana L
Clin Sci (Lond); 2015 Jun; 128(12):877-82. PubMed ID: 25649668
[TBL] [Abstract][Full Text] [Related]
18. Blood lipid tests in 2017.
Couderc R; Antar M; Bonnefont-Rousselot D; Paul JL; Therond P
Ann Biol Clin (Paris); 2017 Dec; 75(6):646-652. PubMed ID: 29072174
[TBL] [Abstract][Full Text] [Related]
19. [The real measurement of non-HDL-cholesterol: Atherogenic cholesterol].
Millán J; Hernández-Mijares A; Ascaso JF; Blasco M; Brea A; Díaz Á; González-Santos P; Mantilla T; Pedro-Botet J; Pintó X;
Clin Investig Arterioscler; 2016; 28(6):265-270. PubMed ID: 27633523
[TBL] [Abstract][Full Text] [Related]
20. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
